Callan Family Office’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
OAG
GIM
Callan Family Office's STE Position: Q2 2026 in Review
Callan Family Office increased its Steris (STE) stake by 1.1% in Q2 2026, buying an estimated $4.93K and bringing the position to 2,104 shares worth $443K. The position accounts for 0.01% of the portfolio, ranked #857.
Callan Family Office first reported a position in STE in Q2 2025 and has held it in 5 quarters since. The position peaked at $842K in Q4 2025. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- Callan Family Office held 2,104 shares of Steris worth $443K as of Q2 2026.
- Callan Family Office bought 23 Steris shares in Q2 2026, an estimated $4.93K.
- Steris made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #857 holding.
- Callan Family Office first reported a position in Steris in Q2 2025 and has held it in 5 quarters since.
- Callan Family Office's Steris position peaked at $842K in Q4 2025.
- 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.